(Total Views: 536)
Posted On: 08/24/2019 10:53:15 PM
Post# of 9144
Re: barniethedino #5154
DinoGuy,
So you provide an old press release about a 19 year old gene company potentially receiving a third of $19 million for what appears to be an existing diagnostic they sell in order to prove the technology works? That’s a sweet deal but you citing the narrative sort of flies in the face of your previous complaints about Nanologix and their development status. Explain how well the gene technology works please. Why isn’t your gene company making money hand over fist? By your logic and that of some others here, why hasn’t big pharma scooped them up? I’m puzzled. We know how well the N-Assay works and how it likely works with any bacteria from the published data. We know how sensitive it is and user friendly. How sensitive is that gene technology? How much do YOU know about biotech, because it doesn’t appear to be much?
Scott
So you provide an old press release about a 19 year old gene company potentially receiving a third of $19 million for what appears to be an existing diagnostic they sell in order to prove the technology works? That’s a sweet deal but you citing the narrative sort of flies in the face of your previous complaints about Nanologix and their development status. Explain how well the gene technology works please. Why isn’t your gene company making money hand over fist? By your logic and that of some others here, why hasn’t big pharma scooped them up? I’m puzzled. We know how well the N-Assay works and how it likely works with any bacteria from the published data. We know how sensitive it is and user friendly. How sensitive is that gene technology? How much do YOU know about biotech, because it doesn’t appear to be much?
Scott
(3)
(1)
